DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
TSVT 2seventy bio
- 2.540
- -0.010-0.39%
Close Feb 14 16:00 ET
- 2.530
- -0.010-0.39%
Post 20:01 ET
131.03MMarket Cap-1.39P/E (TTM)
2.670High2.530Low153.75KVolume2.570Open2.550Pre Close398.16KTurnover0.36%Turnover RatioLossP/E (Static)51.59MShares6.00052wk High0.57P/B107.20MFloat Cap2.29052wk Low--Dividend TTM42.20MShs Float64.000Historical High--Div YieldTTM5.49%Amplitude1.535Historical Low2.589Avg Price1Lot Size
About 2seventy bio Company
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.
Company Profile
SymbolTSVT
Company Name2seventy bio
Listing DateOct 18, 2021
Founded2021
CEOMr. William D. Baird, III
MarketNASDAQ
Employees274
Fiscal Year Ends12-31
Address60 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-339-499-9300
Websitehttp://www.2seventybio.com
Company Executives
- Name
- Position
- Salary
- William D. Baird, III
- Director, President and Chief Executive Officer
- 2.93M
- Jessica Snow
- Chief Operating Officer
- --
- Victoria Eatwell
- Chief Financial Officer and Principal Accounting Officer
- --
- Nick Leschly
- Chairman of the Board
- 9.08M
- Charles Newton
- Independent Director
- --
- Denice M. Torres, J.D.,M.B.A.
- Lead Independent Director
- 304.00K
- Dr. Wei Lin
- Independent Director
- 622.05K
- Dr. Marcela V. Maus
- Independent Director
- 290.00K
- Eli D. Casdin, M.B.A.
- Independent Director
- --
- Sarah Glickman
- Independent Director
- 303.00K